RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RadNet Inc.

Barclays analyst Andrew Mok CFA maintained a Buy rating on Radnet today and set a price target of $86.00. Mok CFA covers the Healthcare sector, foc...

Barclays Reaffirms Their Buy Rating on Radnet (RDNT)

Barclays analyst Andrew Mok CFA maintained a Buy rating on Radnet today and set a price target of $79.00. According to TipRanks, Mok CFA is an anal...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RDNT	$83.00	+4.72%	1.16M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RDNT	$83.00	+4.7%	1.16M
3
4
5
6

RDNT

RDNT

Latest News for RDNT

Get RadNet Inc. Data in Excel

Get RadNet Inc. Data in Excel